Drug evaluation by biopharmaceutics classification system

被引：0
|
作者：
Baek, MS [1 ]
Choi, SO [1 ]
Park, KS [1 ]
Jung, SH [1 ]
Yoon, KE [1 ]
Chung, SY [1 ]
机构：
[1] Korea Food & Drug Adm, Natl Inst Toxicol Res, Div Bioequivalence, Seoul 122704, South Korea
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
432
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [41] The utility of rat jejunal permeability for biopharmaceutics classification system
    Zakeri-Milani, Parvin
    Valizadeh, Hadi
    Tajerzadeh, Hosnieh
    Islambulchilar, Ziba
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (12) : 1496 - 1502
  • [42] Biopharmaceutics classification system: The scientific basis for biowaiver extensions
    Yu, LX
    Amidon, GL
    Polli, JE
    Zhao, H
    Mehta, MU
    Conner, DP
    Shah, VP
    Lesko, LJ
    Chen, ML
    Lee, VHL
    Hussain, AS
    PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 921 - 925
  • [43] Biopharmaceutics classification system: importance and inclusion in biowaiver guidance
    Arrunategui, Lorena Barbosa
    Silva-Barcellos, Neila Marcia
    Bellavinha, Karime Rezende
    Ev, Lisiane da Silveira
    de Souza, Jacqueline
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 51 (01) : 143 - 154
  • [44] Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products Part I: Biopharmaceutics and formulation considerations
    Martinez, M
    Augsburger, L
    Johnston, T
    Jones, WW
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (06) : 805 - 824
  • [45] Impact of Biopharmaceutics Classification System-Based Biowaivers
    Cook, Jack A.
    Davit, Barbara M.
    Polli, James E.
    MOLECULAR PHARMACEUTICS, 2010, 7 (05) : 1539 - 1544
  • [46] Hepatic Clearance Predictions from In Vitro-In Vivo Extrapolation and the Biopharmaceutics Drug Disposition Classification System
    Bowman, Christine M.
    Benet, Leslie Z.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (11) : 1731 - 1735
  • [47] iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
    Forbes, Ben
    Backman, Per
    Cabal, Antonio
    Clark, Andy
    Ehrhardt, Carsten
    Hastedt, Jayne E.
    Hickey, Anthony J.
    Hochhaus, Guenther
    Jiang, Wenlei
    Kassinos, Stavros
    Kuehl, Philip J.
    Olsson, Bo
    Prime, David
    Son, Yoen-Ju
    Teague, Simon
    Tehler, Ulrika
    Wylie, Jennifer
    MOLECULAR PHARMACEUTICS, 2025, 22 (04) : 1740 - 1751
  • [48] Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of Class I drugs
    Khan, M. Zahirul I.
    Rausl, Dragica
    Radosevic, Senka
    Filic, Darko
    Danilovski, Aleksandar
    Dumic, Mijenko
    Knezevic, Zdravka
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (11) : 1475 - 1482
  • [49] Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
    Wu, CY
    Benet, LZ
    PHARMACEUTICAL RESEARCH, 2005, 22 (01) : 11 - 23
  • [50] Generative Topographic Mapping-Based Classification Models and Their Applicability Domain: Application to the Biopharmaceutics Drug Disposition Classification System (BDDCS)
    Gaspar, Helena A.
    Marcou, Gilles
    Horvath, Dragos
    Arault, Alban
    Lozano, Sylvain
    Vayer, Philippe
    Varnek, Alexandre
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (12) : 3318 - 3325
12345